In the formerly (like 20 years ago) sleepy coastal town of Carlsbad, California—today better known for surgical screws than surfboards—an AI spine technology emerging growth company is quietly reshaping the spine surgery industry. And if Carlsmed, Inc.’s initial public offering (IPO) succeeds, they just might do to traditional spine fusion what Netflix did to Blockbuster.
On Thursday, Carlsmed filed paperwork with the Securities and Exchange Commission to raise up to $100 million in an IPO, aiming to trade on the Nasdaq under the ticker symbol CARL. That’s a bold move for a company that’s only been around since 2018. But then again, Carlsmed isn’t your average spine technology startup.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
